• Dr. Nora Volkow Director, National Institute on Drug Abuse, National Institutes of Health Witness Statement [PDF]
  • Dr. Douglas Throckmorton Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research, Food and Drug Administration Witness Statement [PDF]
  • Mr. Matthew Strait Senior Policy Advisor, Diversion Control Division, Drug Enforcement Administration Witness Statement [PDF]

Supporting Documentation

  • Briefing Memo [PDF]
  • Notice of Hearing [PDF]

Video of Proceedings

Data will display when it becomes available.

Text of Legislation

  • H.R. 3797, the “Medical Marijuana Research Act of 2019” [PDF]
  • H.R. 2843, the "Marijuana Freedom and Opportunity Act" [PDF]
  • H.R. 1151, the “Veterans Medical Marijuana Safe Harbor Act” [PDF]
  • H.R. 3884, the “Marijuana Opportunity Reinvestment and Expungement Act of 2019” or the “MORE Act of 2019” [PDF]
  • H.R. 171, the “Legitimate Use of Medicinal Marijuana Act” [PDF]
  • H.R. 601, the “Medical Cannabis Research Act of 2019” [PDF]